Michael Lattanzi - Dissemin

All papers authored by Michael Lattanzi

This paper was not found in any repository, but could be made available legally by the author.

2023 Brendan J. Guercio

, Michal Sarfaty

, Min Yuen Teo

, Neha Ratna

, Cihan Duzgol

, Samuel A. Funt

, Chung-Han Lee

, David H. Aggen

, Ashley M. Regazzi

, Ziyu Chen

, Michael Lattanzi

, Hikmat A. Al-Ahmadie

, A. Rose Brannon

, Ronak Shah

, Carissa Chu

and 8 other authors

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Anna Pavlick, Ana B. Blazquez, Marcia Meseck, Michael Lattanzi

, Patrick A. Ott, Thomas U. Marron, Rose Marie Holman, John Mandeli, Andres M. Salazar, Christopher B. McClain, Gustavo Gimenez, Sreekumar Balan, Sacha Gnjatic, Rachel Lubong Sabado, Nina Bhardwaj

Supplementary Fig 2 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Upload

Anna Pavlick, Ana B. Blazquez, Marcia Meseck, Michael Lattanzi

, Patrick A. Ott, Thomas U. Marron, Rose Marie Holman, John Mandeli, Andres M. Salazar, Christopher B. McClain, Gustavo Gimenez, Sreekumar Balan, Sacha Gnjatic, Rachel Lubong Sabado, Nina Bhardwaj

Supplementary Fig 3 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Upload

Anna Pavlick, Ana B. Blazquez, Marcia Meseck, Michael Lattanzi

, Patrick A. Ott, Thomas U. Marron, Rose Marie Holman, John Mandeli, Andres M. Salazar, Christopher B. McClain, Gustavo Gimenez, Sreekumar Balan, Sacha Gnjatic, Rachel Lubong Sabado, Nina Bhardwaj

Supplementary Table 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Upload

Anna Pavlick, Ana B. Blazquez, Marcia Meseck, Michael Lattanzi

, Patrick A. Ott, Thomas U. Marron, Rose Marie Holman, John Mandeli, Andres M. Salazar, Christopher B. McClain, Gustavo Gimenez, Sreekumar Balan, Sacha Gnjatic, Rachel Lubong Sabado, Nina Bhardwaj

Supplementary Fig 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Upload

Anna Pavlick, Ana B. Blazquez, Marcia Meseck, Michael Lattanzi

, Patrick A. Ott, Thomas U. Marron, Rose Marie Holman, John Mandeli, Andres M. Salazar, Christopher B. McClain, Gustavo Gimenez, Sreekumar Balan, Sacha Gnjatic, Rachel Lubong Sabado, Nina Bhardwaj

Supplementary Figure Legend from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Upload

Anna Pavlick, Ana B. Blazquez, Marcia Meseck, Michael Lattanzi

, Patrick A. Ott, Thomas U. Marron, Rose Marie Holman, John Mandeli, Andres M. Salazar, Christopher B. McClain, Gustavo Gimenez, Sreekumar Balan, Sacha Gnjatic, Rachel Lubong Sabado, Nina Bhardwaj

Data from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Upload

This paper is made freely available by the publisher.

2022 Michael Lattanzi

, Samuel A. Funt

, Jonathan E. Rosenberg

Reply to S. Zhang

Download from doi.org

Samuel A. Funt

, Michael Lattanzi

, Karissa Whiting

, Hikmat Al-Ahmadie

, Colleen Quinlan, Min Yuen Teo

, Chung-Han Lee

, David Aggen

, Danielle Zimmerman

, Deaglan McHugh

, Arlyn Apollo, Trey D. Durdin

, Hong Truong

, Jeffrey Kamradt, Maged Khalil and 24 other authors

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Download from doi.org

Distributing this paper is prohibited by the publisher

2020 Michael Lattanzi

, Jonathan E. Rosenberg

The emerging role of antibody-drug conjugates in urothelial carcinoma

Upload

2019 Anna Pavlick, Ana B. Blazquez, Marcia Meseck, Michael Lattanzi

, Patrick A. Ott, Thomas U. Marron, Rose Marie Holman, John Mandeli, Andres M. Salazar, Christopher B. McClain

, Gustavo Gimenez, Sreekumar Balan

, Sacha Gnjatic

, Rachel Lubong Sabado, Nina Bhardwaj

Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Download from aacrjournals.org

Michael Lattanzi

, Lily M. Tredwin, Fang-Ming Deng, Luis Chiriboga, Briana Zeck, Claudio Forcato, Jonathan Serrano, Hussein Mohamed, Matija Snuderl, Arjun Vasant Balar

Single cell analysis of urothelial carcinoma (UC) liver metastases identifies epithelial-mesenchymal transition (EMT) as a potential mechanism of resistance to immunotherapy.

Download from doi.org

Michael Lattanzi

, Arjun V. Balar

Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma

Download from link.springer.com

2018 Michael Lattanzi

, Fang-Ming Deng, Luis A. Chiriboga, Alisa N. Femia, Shane A. Meehan, Gopa Iyer, Martin H. Voss, Yuliya Sundatova, William C. Huang, Arjun V. Balar

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Download from link.springer.com

Michael Lattanzi

, Yesung Lee, Danny Simpson, Una Moran, Farbod Darvishian, Randie H. Kim, Eva Hernando, David Polsky, Doug Hanniford, Richard Shapiro, Russell Berman, Anna C. Pavlick, Melissa A. Wilson, Tomas Kirchhoff, Jeffrey S. Weber

and 2 other authors

Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy

Download from academic.oup.com

Michael Lattanzi

, Joseph Han, Una Moran, Kierstin Utter, Jeremy Tchack, Rachel Lubong Sabado, Russell Berman, Richard Shapiro, Hsin-Hui Huang, Iman Osman, Nina Bhardwaj

, Anna C. Pavlick

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis

Download from link.springer.com

Michael Lattanzi

, Michael Pacold, Arjun Vasant Balar

Association of upregulation of serine and one carbon metabolism genes with shorter recurrence-free and overall survival in urothelial bladder cancer (UBC).

Download from doi.org

2017 Michael Lattanzi

, Yesung Lee, Eric Michael Robinson, Sarah A. Weiss, Una Moran, Danny Simpson, Richard L. Shapiro, Russell S. Berman, Anna C. Pavlick, Melissa Wilson, Tomas Kirchhoff, Judy Zhong, Iman Osman

Primary melanoma histologic subtype (HS) impacts melanoma specific survival (MSS) and response to systemic therapy.

Download from doi.org

2016 Michael William Lattanzi

, Joseph Han, Una Moran, Kiersten Utter, Jeremy Tchack, Rachel Lubong Sabado, Nina Bhardwaj, Iman Osman, Anna C. Pavlick

Retrospective cohort analysis of adjuvant NY-ESO-1 vaccines in stage III melanoma.

Download from doi.org

2011 Qi Lu, Michael W. Lattanzi

, Yunpeng Chen, Xiaoming Kou, Wanfeng Li, Xin Fan

, Karl M. Unruh, Jingguang G. Chen, John Q. Xiao

Supercapacitor Electrodes with High-Energy and Power Densities Prepared from Monolithic NiO/Ni Nanocomposites

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Michael Lattanzi